|
|
||||
|
Lemons into Lemonade
The growing trend of spin-outs helps companies cash out on underappreciated assets
Email: Susan Warner - swarner@the-scientist.com The Scientist 2005, 19(17):40
|
||||
|
|
||||
|
Before 2001, the company now known as Biovitrum was a group of workers with roots in Pharmacia Corp.'s Swedish research division, which was deemed redundant after Pharmacia merged with Upjohn in 1995. But there was intellectual property and promising research on metabolic disease laying dormant, so in 2001 a management group, along with venture capital investors, used $130 million in new funding to spin the company out of Pharmacia.
|
|
|||||||||
|
|||||||||
|